Alvotech Holdings, headquartered in Reykjavik, has entered into an amendment and restatement agreement with bondholders of its US$300m convertible bond issued on December 14, 2018. Bondholders have exercised their conversion rights on approximately one quarter of the value of the bond, converting US$106m of principal and accrued interest into equity at an exercise price that…
Home Healthcare Markets International News Iceland: Alvotech amends terms on CB after US$106m converted to shares